Ad
related to: preformation concepts in modern pharmaceutics 1 for free students
Search results
Results From The WOW.Com Content Network
A homonculus inside a sperm cell, as drawn by Nicolaas Hartsoeker in 1695 Jan Swammerdam, Miraculum naturae sive uteri muliebris fabrica, 1729. In the history of biology, preformationism (or preformism) is a formerly popular theory that organisms develop from miniature versions of themselves.
The preformation theory is a developmental biological theory, which was represented in antiquity by the Greek philosopher Anaxagoras. It reappeared in modern times in the 17th century and then prevailed until the 19th century.
The history of pharmacy as a modern and independent science dates back to the first third of the 19th century. Before then, pharmacy evolved from antiquity as part of medicine . Before the advent of pharmacists, there existed apothecaries that worked alongside priests and physicians in regard to patient care.
[1] Formulation studies then consider such factors as particle size, polymorphism, pH, and solubility, as all of these can influence bioavailability and hence the activity of a drug. The drug must be combined with inactive ingredients by a method that ensures that the quantity of drug present is consistent in each dosage unit e.g. each tablet ...
The pharmaceutical sciences are a group of interdisciplinary areas of study concerned with the design, manufacturing, action, delivery, and classification of drugs. They apply knowledge from chemistry ( inorganic , physical , biochemical and analytical ), biology ( anatomy , physiology , biochemistry , cell biology , and molecular biology ...
Pharmaceutics is the discipline of pharmacy that deals with the process of turning a new chemical entity (NCE) or an existing drug into a medication to be used safely and effectively by patients. [1] The patients could be either humans or animals. Pharmaceutics helps relate the formulation of drugs to their delivery and disposition in the body. [2]
The phrase "drug design" is similar to ligand design (i.e., design of a molecule that will bind tightly to its target). [6] Although design techniques for prediction of binding affinity are reasonably successful, there are many other properties, such as bioavailability, metabolic half-life, and side effects, that first must be optimized before a ligand can become a safe and effictive drug.
Pharmaceutical Development and Regulation 1 ((3)), 159–168. Werner, E., In silico multicellular systems biology and minimal genomes, DDT vol 8, no 24, pp 1121–1127, Dec 2003. (Introduces the concepts MCPD and Net-MCPD) Dr. David W. A. Bourne, OU College of Pharmacy Pharmacokinetic and Pharmacodynamic Resources.